Kinobead/LC-MS Phosphokinome Profiling Enables Rapid Analyses of Kinase-Dependent Cell Signaling Networks.


Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
06 03 2020
Historique:
pubmed: 11 2 2020
medline: 22 6 2021
entrez: 11 2 2020
Statut: ppublish

Résumé

Kinase-catalyzed protein phosphorylation is fundamental to eukaryotic signal transduction, regulating most cellular processes. Kinases are frequently dysregulated in cancer, inflammation, and degenerative diseases, and because they can be inhibited with small molecules, they became important drug targets. Accordingly, analytical approaches that determine kinase activation states are critically important to understand kinase-dependent signal transduction and to identify novel drug targets and predictive biomarkers. Multiplexed inhibitor beads (MIBs or kinobeads) efficiently enrich kinases from cell lysates for liquid chromatography-mass spectrometry (LC-MS) analysis. When combined with phosphopeptide enrichment, kinobead/LC-MS can also quantify the phosphorylation state of kinases, which determines their activation state. However, an efficient kinobead/LC-MS kinase phospho-profiling protocol that allows routine analyses of cell lines and tissues has not yet been developed. Here, we present a facile workflow that quantifies the global phosphorylation state of kinases with unprecedented sensitivity. We also found that our kinobead/LC-MS protocol can measure changes in kinase complex composition and show how these changes can indicate kinase activity. We demonstrate the utility of our approach in specifying kinase signaling pathways that control the acute steroidogenic response in Leydig cells; this analysis establishes the first comprehensive framework for the post-translational control of steroid biosynthesis.

Identifiants

pubmed: 32037842
doi: 10.1021/acs.jproteome.9b00742
pmc: PMC7537592
mid: NIHMS1627235
doi:

Substances chimiques

Protein Kinases EC 2.7.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1235-1247

Subventions

Organisme : NCI NIH HHS
ID : K22 CA201229
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM129090
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR065459
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA177402
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM086858
Pays : United States
Organisme : NIH HHS
ID : S10 OD021502
Pays : United States
Organisme : NIBIB NIH HHS
ID : R21 EB018384
Pays : United States

Références

Annu Rev Biochem. 2012;81:587-613
pubmed: 22482904
Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20
pubmed: 25514926
Trends Biochem Sci. 2019 Mar;44(3):273-292
pubmed: 30415968
Methods Mol Biol. 2017;1636:105-117
pubmed: 28730476
Mol Cell Endocrinol. 2004 Mar 31;217(1-2):109-12
pubmed: 15134808
Mol Cell Proteomics. 2010 Jun;9(6):1047-62
pubmed: 20071362
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
Nat Chem Biol. 2005 Oct;1(5):252-62
pubmed: 16408053
ACS Chem Biol. 2013 Jan 18;8(1):96-104
pubmed: 23276252
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
J Proteome Res. 2010 May 7;9(5):2539-49
pubmed: 20222745
ACS Chem Biol. 2015 Dec 18;10(12):2743-52
pubmed: 26378887
Mol Cell Proteomics. 2010 Jun;9(6):1167-81
pubmed: 20097925
J Proteome Res. 2005 Nov-Dec;4(6):2397-403
pubmed: 16335993
Science. 2002 Dec 6;298(5600):1912-34
pubmed: 12471243
Nat Rev Drug Discov. 2018 May;17(5):353-377
pubmed: 29545548
Mol Syst Biol. 2005;1:2005.0008
pubmed: 16729043
J Biol Chem. 2002 Jan 4;277(1):609-17
pubmed: 11682487
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4617-22
pubmed: 19255428
Endocrinology. 2013 Jan;154(1):511-20
pubmed: 23183170
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Mol Cell. 2008 Aug 8;31(3):438-48
pubmed: 18691976
Endocrinology. 2006 Nov;147(11):5460-9
pubmed: 16916946
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629
pubmed: 28397828
Mol Omics. 2018 Feb 12;14(1):26-36
pubmed: 29725679
Methods Mol Biol. 2016;1355:251-60
pubmed: 26584931
Cell Rep. 2014 Sep 11;8(5):1583-94
pubmed: 25159151
Biochim Biophys Acta. 2007 Jun;1771(6):663-76
pubmed: 17433772
Nutr Metab (Lond). 2010 Jun 01;7:47
pubmed: 20515451
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5685-93
pubmed: 27601673
Cell Signal. 2016 Jul;28(7):764-78
pubmed: 26643407
Nat Protoc. 2008;3(10):1630-8
pubmed: 18833199
Nat Rev Cancer. 2016 Feb;16(2):83-98
pubmed: 26822576
Endocr Rev. 2011 Feb;32(1):81-151
pubmed: 21051590
Mol Cell Proteomics. 2009 Jul;8(7):1751-64
pubmed: 19369195
J Proteome Res. 2017 Mar 3;16(3):1216-1227
pubmed: 28102076
Nucleic Acids Res. 2017 Jan 4;45(D1):D369-D379
pubmed: 27980099
Int J Mol Sci. 2015 Feb 05;16(2):3537-63
pubmed: 25664860
Mol Endocrinol. 2005 Nov;19(11):2647-59
pubmed: 15831519
Endocr Rev. 2002 Apr;23(2):141-74
pubmed: 11943741
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Anal Chem. 2009 Jun 1;81(11):4566-75
pubmed: 19408940
Medchemcomm. 2014 Mar;5(3):363-369
pubmed: 24648882
Bioinformation. 2007 May 20;2(1):5-7
pubmed: 18084642
Mol Cell. 2004 Sep 10;15(5):661-75
pubmed: 15350212
Nat Biotechnol. 2007 Sep;25(9):1035-44
pubmed: 17721511
Cell. 2006 Nov 3;127(3):635-48
pubmed: 17081983
Trends Plant Sci. 2018 Dec;23(12):1068-1080
pubmed: 30279071
Curr Pharm Des. 2017 Nov 16;23(29):4209-4225
pubmed: 28730960
J Mol Endocrinol. 2014 Aug;53(1):1-16
pubmed: 24780837
Proteomics. 2014 Mar;14(4-5):513-24
pubmed: 24339426
Nat Rev Mol Cell Biol. 2010 Jun;11(6):427-39
pubmed: 20461098
Lipids. 2008 Dec;43(12):1109-15
pubmed: 18726632

Auteurs

Martin Golkowski (M)

Department of Pharmacology, University of Washington, Seattle, Washington 98195, United States.

Venkata Narayana Vidadala (VN)

Department of Chemistry, University of Washington, Seattle, Washington 98195, United States.

Ho-Tak Lau (HT)

Department of Pharmacology, University of Washington, Seattle, Washington 98195, United States.

Anna Shoemaker (A)

Department of Pharmacology, University of Washington, Seattle, Washington 98195, United States.

Masami Shimizu-Albergine (M)

University of Washington Medicine Diabetes Institute, University of Washington, Seattle, Washington 98109, United States.

Joseph Beavo (J)

Department of Pharmacology, University of Washington, Seattle, Washington 98195, United States.

Dustin J Maly (DJ)

Department of Chemistry, University of Washington, Seattle, Washington 98195, United States.

Shao-En Ong (SE)

Department of Pharmacology, University of Washington, Seattle, Washington 98195, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH